INHSU 2024

8-11 October 2024

Megaron International Convention Centre
Athens, Greece

The 12th International Conference
on Health and Hepatitis
in Substance Users

Sign up for alerts




INHSU 2024 will feature over 100+ sessions on epidemiology and public health research, clinical research, social science and policy research, and good practice models of care for people who use drugs.


Keynote speakers

Professor Alison Ritter, DPMP (Drug Policy Modelling Program)
UNSW Sydney, Australia

Presenting: Drug Policy Reform:
Evaluation of decriminalisation and regulation models

Dr. Thomas Kerr
The University of British Columbia, Canada
Safer supply: A critical review of different models and their impact.

Matt Southwell, EuroNPUD, UK
Innovation in NSP programming: what works and what’s coming

Dr. Nadine Kronfli, McGill University, Canada
Global Picture of Harm Reduction Programming in Prisons.


Invited speakers

Dr. Saeed Hamid, The Aga Khan University, Pakistan

Innovations in testing for HCV

Sarah Larney, Université de Montréal, Canada

Presenting: Addressing gender disparities in HCV testing and treatment uptake: Providing gender responsive models of care

 Dr. Julie Bruneau
Université de Montréal, Canada

Presenting: Clinical considerations for opioid agonist treatment (OAT) selection and delivery

Charles Henderson
Burnet Institute, Melbourne, Australia

Presenting: Understanding patient preferences and decision-making for opioid agonist therapies

George Papatheodoridis
Athens Medical School and Laiko Hospital, Athens, Greece

Presenting: Innovations in therapeutic developments for HBV and HDV

Dr. Joshua Barocas, University of Colorado School of Medicine, oThe Missing US Lab Project, Social Determinants of Health and Disparities Modeling Unit, USA

Presenting: Future therapies for skin and soft tissue infections in people who inject drugs

Dr. Vana Sypsa
National and Kapodistrian University of Athens

Presenting: HCV elimination progress in people who inject drugs